Literature DB >> 2417553

The anticholinergic anti-Parkinson drug Norakin selectively inhibits influenza virus replication.

C Schroeder, H Heider, B Hegenscheid, M Schöffel, V I Bubovich, H A Rosenthal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2417553     DOI： 10.1016/s0166-3542(85)80014-0

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


× No keyword cloud information.
  4 in total

1.  Mutations in the hemagglutinin gene associated with influenza virus resistance to norakin.

Authors:  S Prösch; H Heider; C Schroeder; D H Krüger
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin.

Authors:  S J Plotch; B O'Hara; J Morin; O Palant; J LaRocque; J D Bloom; S A Lang; M J DiGrandi; M Bradley; R Nilakantan; Y Gluzman
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

3.  Relation between drug resistance and antigenicity among norakin-resistant mutants of influenza A (fowl plague) virus.

Authors:  A I Klimov; S G Markushin; S Prösch; V P Ginzburg; H Heider; A M Heider; C Schröeder; R G Webster
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 4.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.